Document is current
Any future updates will be listed below
-
Authors
Budzinski, Julian
Maschauer, Simone
Kobayashi, Hiroyuki https://orcid.org/0000-0003-4965-0883
Couvineau, Pierre https://orcid.org/0000-0002-4905-7740
Vogt, Hannah
Gmeiner, Peter https://orcid.org/0000-0002-4127-197X
Roggenhofer, Anna
Prante, Olaf
Bouvier, Michel https://orcid.org/0000-0003-1128-0100
Weikert, Dorothee https://orcid.org/0000-0003-2259-9002
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (GRK1910)
Gouvernement du Canada | Canadian Institutes of Health Research (148431)
Canada Research Chairs (Signal Transduction and Molecular Pharmacology)
- License Information
-
More Information
Article History
Received: 22 September 2020
Accepted: 18 August 2021
First Online: 10 September 2021
Competing interests
: The authors declare the following competing interests: some of the biosensors used in this study were licensed to Domain Therapeutics for commercial use but are freely available for academic research upon request. M.B. is the president of the scientific advisory board of Domain Therapeutics. The remaining authors declare no competing interests.
